Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
Yoshimura
N
N
Kyoto Prefectural Yosanoumi Hospital, Yosagun, Japan.
Ohmori
Y
Y
Tsuji
T
T
Oka
T
T
D001379:Azathioprine / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood*; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D017035:Pravastatin / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D011239:Prednisolone; D017035:Pravastatin; D001379:Azathioprine